DBV Technologies (DBVT) Operating Expenses (2020 - 2026)
DBV Technologies (DBVT) posted Operating Expenses of $51.3 million for Q2 2026, up 5.12% sequentially from $48.8 million in Q1 2026, and up 20.42% YoY from $42.6 million in Q2 2025.
DBV Technologies (DBVT) Operating Expenses (2020 - 2026) Analysis & Trends
DBV Technologies has reported Operating Expenses for 7 years, with the latest figure at $51.3 million in Q2 2026.
- Quarterly Operating Expenses rose 20.42% year-over-year to $51.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $182.8 million (up 45.38% YoY) and the FY2025 annual result came in at $152.7 million, up 26.46% from the prior year.
- Operating Expenses grew to $51.3 million in Q2 2026 per DBVT's latest filing, from $48.8 million in the prior quarter.
- Over five years, Operating Expenses peaked at $51.3 million in Q2 2026 and troughed at $19.3 million in Q1 2022.
- A 5-year average of $31.5 million and a median of $28.7 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses soared 123.71% in 2022, then sank 43.36% in 2023.
- Over 5 years, Operating Expenses stood at $36.7 million in 2022, then tumbled by 43.36% to $20.8 million in 2023, then grew by 17.2% to $24.4 million in 2024, then jumped by 87.49% to $45.7 million in 2025, then gained by 12.27% to $51.3 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $51.3 million, $48.8 million, and $45.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | DBV Technologies | 6.08 Bn | 5.90 Bn | - | 51.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51.30 Mn |
| Mar 31, 2026 | 48.80 Mn |
| Dec 31, 2025 | 45.70 Mn |
| Sep 30, 2025 | 37.05 Mn |
| Jun 30, 2025 | 42.60 Mn |
| Mar 31, 2025 | 27.40 Mn |
| Dec 31, 2024 | 24.37 Mn |
| Sep 30, 2024 | 31.40 Mn |
| Jun 30, 2024 | 35.00 Mn |
| Mar 31, 2024 | 29.96 Mn |
| Dec 31, 2023 | 20.80 Mn |
| Sep 30, 2023 | 20.64 Mn |
| Jun 30, 2023 | 27.36 Mn |
| Mar 31, 2023 | 23.36 Mn |
| Dec 31, 2022 | 36.71 Mn |
| Sep 30, 2022 | 20.09 Mn |
| Jun 30, 2022 | 25.35 Mn |
| Mar 31, 2022 | 19.32 Mn |
| Dec 31, 2021 | 16.41 Mn |
| Sep 30, 2021 | 25.69 Mn |